Population pharmacokinetics of olanzapine in pediatric patients with psychiatric disorders-Reference-Cited by-同舟云学术

Population pharmacokinetics of olanzapine in pediatric patients with psychiatric disorders

Published:2024-07-23 Issue: Volume: Page:1-14
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Zang Yan-Nan¹²^ORCID,Wan Zhou¹²^ORCID,Jia Fei¹²^ORCID,Yang Qi¹²^ORCID,Liu Chen-Geng¹²^ORCID,Wang Qian¹²^ORCID,Liu Shan-Shan¹²^ORCID,Dong Fang¹²^ORCID,Li An-Ning¹²,de Leon Jose³⁴^ORCID,Wang Gang¹²^ORCID,Ruan Can-Jun¹²^ORCID

Affiliation:

1. The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China

2. Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China

3. Mental Health Research Center at Eastern State Hospital, Lexington, KY, USA

4. Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain

Funder

Beijing Municipal Science & Technology Commission

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2024.2380472

Reference59 articles.

1. Prevalence of mental disorders in school children and adolescents in China: diagnostic data from detailed clinical assessments of 17,524 individuals

2. A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics

3. Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical Practice

4. National Library of Medicine (US). Label: olanzapine-olanzapine tablet in Dailymed. Dailymed web site. [cited 2021 Jul 27]. Available from: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d974d2a4-fc65-42ff-8138cfcfd7381534

5. A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration